Proteoliposomes as tool for assaying membrane transporter functions and interactions with xenobiotics
GLP-1 receptor agonists are large peptide molecules with molecular weights exceeding 4,000 Daltons, making significant passage into breast milk biologically unlikely
Apart from its unclear safety profile in clinical research, we can conclude, based on our dealings with prescribers, that KPV administered subcutaneously can cause certain side effects that are common to most therapeutic peptide injectables: injection site reactions and mild, transient flu-like symptoms
Topical and Injectable GHK-Cu Routes Compared Topical GHK-Cu has published cosmetic, wound, and trial-context evidence, while injectable GHK-Cu lacks an FDA-approved dosing label and is specifically discussed by FDA in relation to compounded injectable safety concerns [2], [3], [7], [8]